MX389112B - Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis. - Google Patents

Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis.

Info

Publication number
MX389112B
MX389112B MX2018011593A MX2018011593A MX389112B MX 389112 B MX389112 B MX 389112B MX 2018011593 A MX2018011593 A MX 2018011593A MX 2018011593 A MX2018011593 A MX 2018011593A MX 389112 B MX389112 B MX 389112B
Authority
MX
Mexico
Prior art keywords
prevention
treatment
probiotics
psoriasis
cect
Prior art date
Application number
MX2018011593A
Other languages
English (en)
Other versions
MX2018011593A (es
Inventor
Boscá Ana Adela Ramírez
Vidal Daniel Ramón
Cortés Francisco Manuel Codoñer
Orquín José Manuel Pérez
Cuadros María Empar Chenoll
Martínez Salvador Genovés
López Vicente Manuel Navarro
Original Assignee
Biopolis SL
Bionou Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopolis SL, Bionou Res S L filed Critical Biopolis SL
Publication of MX2018011593A publication Critical patent/MX2018011593A/es
Publication of MX389112B publication Critical patent/MX389112B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición probiótica que comprende Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium Iongum y Lactobacillus rhamnosus, en particular, las cepas B. lactis CECT 8145, B. Iongum ES1 CECT 7347 y/o L. rhamnosus CECT 8361, en el tratamiento y/o prevención de los brotes de psoriasis o la psoriasis.
MX2018011593A 2016-03-21 2017-03-21 Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis. MX389112B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382122.6A EP3222282A1 (en) 2016-03-21 2016-03-21 Use of probiotics in the treatment and/or prevention of psoriasis
PCT/EP2017/056719 WO2017162683A1 (en) 2016-03-21 2017-03-21 Use of probiotics in the treatment and/or prevention of psoriasis

Publications (2)

Publication Number Publication Date
MX2018011593A MX2018011593A (es) 2020-01-30
MX389112B true MX389112B (es) 2025-03-20

Family

ID=55969084

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011593A MX389112B (es) 2016-03-21 2017-03-21 Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis.

Country Status (24)

Country Link
US (1) US10912802B2 (es)
EP (2) EP3222282A1 (es)
KR (1) KR102303587B1 (es)
CN (1) CN110325198B (es)
AR (1) AR107921A1 (es)
AU (1) AU2017238300B2 (es)
DK (1) DK3432899T3 (es)
EA (1) EA201891908A1 (es)
ES (1) ES2873889T3 (es)
HR (1) HRP20211173T1 (es)
HU (1) HUE055635T2 (es)
IL (1) IL261932B2 (es)
MA (1) MA43488B1 (es)
MX (1) MX389112B (es)
MY (1) MY193275A (es)
PE (1) PE20190432A1 (es)
PH (1) PH12018502042B1 (es)
PL (1) PL3432899T3 (es)
PT (1) PT3432899T (es)
RS (1) RS62101B1 (es)
RU (1) RU2767967C2 (es)
SI (1) SI3432899T1 (es)
UA (1) UA127180C2 (es)
WO (1) WO2017162683A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800002052A1 (it) * 2018-01-26 2019-07-26 Girolamo Stefano Di Probiotico per il trattamento della psoriasi
EP3851115A1 (en) * 2020-01-15 2021-07-21 Biopolis, S.L. Probiotic composition for its use as an antioxidant
US20210275612A1 (en) * 2020-03-09 2021-09-09 Glac Biotech Co., Ltd. Method for alleviating inflammation-related disorder
CN113142554A (zh) * 2020-06-09 2021-07-23 江苏佰澳达生物科技有限公司 一种改善头皮屑产生的益生菌发酵液及其应用
EP3967318A1 (en) 2020-09-14 2022-03-16 Bionou Research, S.L. Probiotic compositions for the treatment of acne
CN112159778B (zh) * 2020-09-30 2021-12-03 江南大学 一株可缓解银屑病的动物双歧杆菌及其应用
WO2022090474A1 (en) * 2020-10-29 2022-05-05 Deerland Probiotics & Enzymes A/S Microencapsulated microbial composition
CN112546074B (zh) * 2020-12-24 2022-09-27 江南大学 一株能够抑制IL-23、Th17轴相关炎症因子释放的短双歧杆菌及其应用
CN112812989B (zh) * 2020-12-31 2022-06-10 江南大学 一种能够缓解银屑病的青春双歧杆菌及其应用
EP4294416A1 (en) * 2021-02-17 2023-12-27 Axisbiotix Limited Composition and use thereof
CN113088473B (zh) * 2021-04-27 2022-08-02 江南大学 一株具有缓解HaCaT细胞氧化损伤作用的动物双歧杆菌
CN113455549B (zh) * 2021-06-29 2022-09-13 黑龙江飞鹤乳业有限公司 一种奶酪产品及其制备方法和应用
KR20240130711A (ko) * 2021-12-16 2024-08-29 바이오폴리스, 에스.엘. 불안 장애의 치료 및/또는 예방에 있어서 포스트바이오틱스의 용도
KR102854932B1 (ko) * 2023-07-03 2025-09-05 코스맥스 주식회사 비피도박테리움 애니멀리스 서브스페시스 락티스 균주 및 그의 모발 또는 두피 상태 개선 용도
CN118421507A (zh) * 2024-04-22 2024-08-02 广东行海生物科技有限公司 一种医用细胞CMU-Pb-12联合地塞米松在制备防治银屑病药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070260A1 (en) * 2002-02-21 2003-08-28 Societe Des Produits Nestle S.A. A photoprotective orally administrable composition for skin
JP2004250337A (ja) 2003-02-18 2004-09-09 Sunstar Inc アレルギー疾患改善用製剤
ZA200802934B (en) * 2005-10-06 2009-09-30 Probi Ab Use of lactobacillus for treatment of virus infections
AU2006297896B2 (en) * 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
ES2343499B1 (es) 2007-12-24 2011-06-10 Consejo Superior De Investigaciones Cientificas Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
PL2704704T3 (pl) * 2011-05-03 2019-04-30 Dupont Nutrition Biosci Aps Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry
KR20130049554A (ko) 2011-11-04 2013-05-14 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
KR101453982B1 (ko) * 2012-09-19 2014-10-28 주식회사 쎌바이오텍 과민성 대장 증후군 예방 또는 치료용 조성물
ES2526986B1 (es) * 2013-07-18 2015-11-02 Biopolis, S.L. Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
KR101724601B1 (ko) 2014-11-04 2017-04-10 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
TWI829098B (zh) * 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物

Also Published As

Publication number Publication date
HUE055635T2 (hu) 2021-12-28
RU2018136939A (ru) 2020-04-22
ES2873889T3 (es) 2021-11-04
AU2017238300A1 (en) 2018-11-01
US10912802B2 (en) 2021-02-09
UA127180C2 (uk) 2023-05-31
AR107921A1 (es) 2018-06-28
IL261932A (en) 2018-10-31
IL261932B2 (en) 2023-04-01
CA3018625A1 (en) 2017-09-28
DK3432899T3 (da) 2021-07-05
KR102303587B1 (ko) 2021-09-17
SI3432899T1 (sl) 2021-12-31
PH12018502042A1 (en) 2019-07-15
EP3432899A1 (en) 2019-01-30
MA43488B1 (fr) 2020-10-28
RU2018136939A3 (es) 2020-05-13
PT3432899T (pt) 2021-07-05
MY193275A (en) 2022-09-29
RS62101B1 (sr) 2021-08-31
MA43488A1 (fr) 2019-12-31
KR20190008849A (ko) 2019-01-25
PL3432899T3 (pl) 2021-11-22
WO2017162683A1 (en) 2017-09-28
EP3222282A1 (en) 2017-09-27
BR112018069284A2 (pt) 2019-03-06
AU2017238300B2 (en) 2024-07-11
PH12018502042B1 (en) 2024-02-21
EA201891908A1 (ru) 2019-04-30
IL261932B (en) 2022-12-01
MX2018011593A (es) 2020-01-30
HRP20211173T1 (hr) 2021-10-15
CN110325198A (zh) 2019-10-11
CN110325198B (zh) 2024-04-30
NZ747129A (en) 2025-02-28
EP3432899B1 (en) 2021-04-28
US20190328799A1 (en) 2019-10-31
PE20190432A1 (es) 2019-03-21
RU2767967C2 (ru) 2022-03-23

Similar Documents

Publication Publication Date Title
PH12018502042B1 (en) Use of probiotics in the treatment and/or prevention of psoriasis
PE20190417A1 (es) Uso de probioticos en el tratamiento y/o la prevencion de la dermatitis atopica
ES2477882T3 (es) Probióticos, IgA secretora e infección
ZA202105310B (en) Probiotic compositions comprising lactobacillus reuteri strains and methods of use
IT201600091033A1 (it) Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
DK3554517T3 (da) Probiotisk sammensætning omfattende lactobacillus rhamnosus og lactobacillus paracasei stammer
HRPK20130487B3 (hr) Formulacija probiotika s apigeninom i ekstraktom paprene metvice
CL2018001936A1 (es) Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación.
MX383473B (es) Empleo de probióticos en el incremento de la fertilidad masculina.
MX382895B (es) Suplemento dietético.
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
EP3601525C0 (en) LACTOBACILLUS CASEI PROBIOTIC STRAIN AND ITS USES
HUE072443T2 (hu) B. longum CECT-7347 és L. rhamnosus CECT-8361 törzseket tartalmazó posztbiotikus készítmények és terápiás alkalmazásuk
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
AR095486A1 (es) Composición nutricional para el tratamiento de emesis idiopática crónica en felinos y canes
PL406051A1 (pl) Zastosowanie kompozycji probiotycznej
Tehrani et al. The effect of some lactobacillus species (probiotics) on biofilm inhibition in Enterococcus faecium
UA120331U (uk) Пробіотик "болмол"
AR095150A1 (es) Combinación farmacéutica oral, útil para restablecer alteraciones de la función intestinal y proceso para prepararla
PL397178A1 (pl) Kompozycja probiotyczna